In January 2021, EBC joined the BRAINTEASER project, which kicked off in partnership with 11 partners, a multidisciplinary gender-balanced consortium from academia, industry, clinical settings and the non-profit sector coming from six European countries. BRAINTEASER intends to become an open, significant success story of how, in the modern healthcare scenario, the integration of clinical knowledge, technical skills and patients’ contributions can drive towards innovative approaches to care and cure. During the four years of the project, the BRAINTEASER study will involve 300 patients enrolled in the four participating clinical centres located in Italy, Spain and Portugal. The patients will be constantly monitored using specific instruments such as sensors and smart apps, designing personalised services and fostering the patients’ empowerment and self-management.

The project is currently still ongoing. Visit the BRAINTEASER website here.